Johnson & Johnson announced plans Friday to invest more than $55 billion in manufacturing, research, and technology across the United States during the next four years.
The investment marks a 25 percent increase over the company’s previous four-year spending, the company said in the March 21 announcement. It comes amid growing pressure on pharmaceutical companies to expand domestic production due to potential tariffs on drug imports.
